[go: up one dir, main page]

PT87920A - Processo de preparacao de inibidores da dopamina-beta-hidroxilase - Google Patents

Processo de preparacao de inibidores da dopamina-beta-hidroxilase

Info

Publication number
PT87920A
PT87920A PT87920A PT8792088A PT87920A PT 87920 A PT87920 A PT 87920A PT 87920 A PT87920 A PT 87920A PT 8792088 A PT8792088 A PT 8792088A PT 87920 A PT87920 A PT 87920A
Authority
PT
Portugal
Prior art keywords
dopamine
beta
preparation
hydroxylase inhibitors
hydroxylase
Prior art date
Application number
PT87920A
Other languages
English (en)
Inventor
Lawrence Ivan Kruse
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of PT87920A publication Critical patent/PT87920A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT87920A 1987-07-09 1988-07-06 Processo de preparacao de inibidores da dopamina-beta-hidroxilase PT87920A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/071,515 US4798843A (en) 1987-07-09 1987-07-09 2-mercaproimidazole dopamine-β-hydroxylase inhibitors

Publications (1)

Publication Number Publication Date
PT87920A true PT87920A (pt) 1989-06-30

Family

ID=22101822

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87920A PT87920A (pt) 1987-07-09 1988-07-06 Processo de preparacao de inibidores da dopamina-beta-hidroxilase

Country Status (7)

Country Link
US (1) US4798843A (pt)
EP (1) EP0302603A1 (pt)
JP (1) JPS6429365A (pt)
AU (1) AU1875988A (pt)
DK (1) DK378988A (pt)
PT (1) PT87920A (pt)
ZA (1) ZA884838B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992459A (en) * 1983-04-12 1991-02-12 Smithkline Beecham Corporation Dopamine-β-hydroxylase inhibitors
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
ES2142789T3 (es) * 1989-06-14 2000-05-01 Smithkline Beecham Corp Acidos imidazolil-alquenoicos.
US7358269B2 (en) * 2002-05-21 2008-04-15 Allergan, Inc. 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
US20060293359A1 (en) * 2003-06-25 2006-12-28 Allergan, Inc. Methods and compositions for the treatment of diabetes
US20050059664A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Novel methods for identifying improved, non-sedating alpha-2 agonists
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
KR20070054213A (ko) * 2004-09-24 2007-05-28 알러간, 인코포레이티드 특이적인 알파2 아드레날린성 아고니스트로서 작용하는4-(페닐메틸 및 치환된 페닐메틸)-이미다졸-2-티온
EP1791832A1 (en) 2004-09-24 2007-06-06 Allergan, Inc. 4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
MX2007003094A (es) * 2004-09-24 2007-06-07 Allergan Inc 4-(metilo ciclico condensado)-imidazol-2-tionas como agonistas alfa2 adrenergicos.
CN101044120B (zh) * 2004-09-28 2011-06-15 阿勒根公司 用作特异性或选择性α2肾上腺素能激动剂的未取代和取代的4-苄基-1,3-二氢-咪唑-2-硫酮及其使用方法
JP2009500409A (ja) * 2005-06-29 2009-01-08 アラーガン、インコーポレイテッド 痛みを処置するためのα２アドレナリン作動剤
FR2917087B1 (fr) * 2007-06-05 2012-09-21 Galderma Res & Dev Nouveaux 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique.
FR2916976B1 (fr) * 2007-06-05 2009-09-04 Galderma Res & Dev Utilisation de 4-phenyl-imidazole-2-thiones comme inhibiteurs de la tyrosinase, pour la preparation de composition pharmaceutiques ou cosmetiques destinees au traitement ou a la prevention des desordres pigmentaires.
WO2009097416A1 (en) * 2008-01-29 2009-08-06 Vanda Pharmaceuticals, Inc. Imidazolylalkyl- pyridines as dbh inhibitors
WO2013134047A2 (en) 2012-03-07 2013-09-12 The Mclean Hospital Corporation Aminoquinoline derivatives and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3701832A (en) * 1969-11-19 1972-10-31 Merck & Co Inc Method of inhibiting dopamine beta-hydroxylase
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors

Also Published As

Publication number Publication date
AU1875988A (en) 1989-01-12
ZA884838B (en) 1989-07-26
DK378988D0 (da) 1988-07-07
EP0302603A1 (en) 1989-02-08
US4798843A (en) 1989-01-17
JPS6429365A (en) 1989-01-31
DK378988A (da) 1989-01-10

Similar Documents

Publication Publication Date Title
PT93830A (pt) Processo de preparacao de perfluropolieteres peroxidicos
PT83643B (pt) Processo de preparacao de derivados de quinoleina
PT83608B (pt) Processo de preparacao de derivados da paroxetina
PT87920A (pt) Processo de preparacao de inibidores da dopamina-beta-hidroxilase
BR8801271A (pt) Processo de neutralizacao de acidos mono-carboxilicos
PT78708A (pt) Processo de preparacao de antibioticos beta-lactamicos
DE69027569D1 (de) Verfahren zur Herstellung von Enynderivaten
PT87642A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors
PT86069A (pt) Processo de preparacao de ureia
PT89901A (pt) Processo de producao de ureias n-sulfonilicas
BR8805636A (pt) Processo de alquilacao
BR8705545A (pt) Processo de preparacao de composto
BR8305451A (pt) Processo de preparacao de derivados de acidos benzoxazolil-e benzotiazolil-oxi-fenoxi-propionicos
PT84624B (pt) Processo de preparacao de imidazois substituidos
PT89491A (pt) Processo de preparacao de polimeros de organoborossilazanos
PT84553B (pt) Processo de preparacao de derivados de indenopirimidina
PT94032A (pt) Processo de preparacao de betao betuminoso contendo pedacos de arame
BR8601349A (pt) Processo de preparar w-lactamas
PT88978A (pt) Processo de preparacao de composicoes farmaceuticas contendo calcitoninas
PT83602B (pt) Processo de preparacao de derivados doacido mandelico
PT87732A (pt) Process for the preparation of (e)-(p-fluorophenethyl)-3-fluoroallylamine
PT81973B (pt) Processo para a preparacao de inibidores da dopamina-beta-hidroxilase
BR9305837A (pt) Processo de preparação de 3-carbonilandrostadieno 17-carboxamidas
BR8805858A (pt) Processo para preparacao de acidos c12-c40-graxos alfa-ramificado
PT81505B (pt) Processo de preparacao de esteres do dietileno-glicol